ARCHIVES

Avastin May Trigger Two FDA Decisions: One On Approval, Another On Withdrawal

This article is from The Cancer Letter archive.

Vol. 36 No. 31 | September 3, 2010

Download PDF Visit The Full Archive

Related Articles

Breast Cancer Incidence Reduced 45% In Tamoxifen Arm Of BCPT; Trial Unblinded

April 10, 1998

“We’re All Filling Up With Carcinogens” Ames Tells NCAB

October 7, 1977

Congress Cuts $210 Million From NIH Budget For The Remainder of 2011

April 15, 2011

National Toxicology Program: Saccharin No Longer Listed as Carcinogen in NTP Report

May 19, 2000

Armand Hammer Panel chairman; DeVita Announces Greenwald Appointment; Adamson To Be DCCP Director

October 9, 1981

Nexavar Improves PFS In Phase III Trial

January 25, 2013